The analysis also revealed the presence of high tumor CD47 expression (HR = 1.75, 95% CI = 1.03–2.98, p = 0.038), lymph node metastasis (HR = 2.26, 95% CI = 1.31–3.91, p = 0.0036), and peritoneal metastasis (HR = 5.80; 95% CI = 3.23–10.43, p < 0.0001) as potential independent risk factors for patients with CRC (Table 3). The gene discussed is CD47; the disease is metastatic malignant neoplasm in the lymph nodes.